AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire
Villejuif, 94800, France
NCT Number: NCT02041637
The purpose of the study is to evaluate the outcome and to determine predictive factors of patients admitted in a context of acute liver failure without identified cause.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Villejuif, 94800, France
Methodology: Multicentric French national cohort with prospective collection of data and constitution of biobank, in patients hospitalized in a context of acute liver failure without known cause at admission. Follow-up during 3 months for each patients. The primary objective is to determine predictive factors of early mortality. This study is an observational cohort and patients will received standard care during the follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At 3 months
Time frame: At 3 months
Time frame: At 3 months
Time frame: At 3 months
Assistance Publique - Hôpitaux de Paris
Other
Unknown Cause of Acute Liver Failure: Determination of Early Mortality Predictive Factors
Acronym: HASIPRO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05045794
Digestive System Diseases, End Stage Liver Disease
San Bernadino, California, United States
View Trial DetailsNCT01022476
Adenocarcinoma, Blood-Borne Infections
Le Kremlin-Bicêtre, France
View Trial DetailsNCT07362745
Digestive System Diseases, End Stage Liver Disease
Xi'an, Shaanxi, China
View Trial DetailsNCT04618692
Digestive System Diseases, Digestive System Neoplasms
Istanbul, Turkey (Türkiye)
View Trial Details